site stats

Galectin stock price

WebMar 17, 2024 · NORCROSS - Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin-3, today reported the positive outcome of its third data and safety monitoring board (DSMB) meeting for NAVIGATE, its seamless, adaptive, phase 2b/3 study of belapectin in patients with liver cirrhosis caused by non … Web8 rows · The 50-day moving average is a frequently used data point by active investors and traders to ...

Galectin Therapeutics Inc. Common Stock (GALT) Stock …

WebApr 10, 2024 · 1 Wall Street analysts have issued 1 year price targets for Galectin Therapeutics' stock. Their GALT share price forecasts range from $11.00 to $11.00. On … WebApr 10, 2024 · GALT Stock Overview. Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for … the shade room kanye https://triple-s-locks.com

Stock Information Galectin Therapeutics Inc.

WebApr 13, 2024 · Galecto to Present Two Posters at AACR Annual Meeting 2024. BOSTON, April 13, 2024 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage … Web18 hours ago · Price To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Galectin Therapeutics (GALT) WebGlobeNewswire. May-28-19 09:05AM. Galectin Therapeutics Raises $44.5 Million in Rights Offering and $2.5 Million from Warrant Exercise. GlobeNewswire. Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. the shade room internship

StockNews.com Begins Coverage on Galectin Therapeutics …

Category:Galectin Therapeutics (Nasdaq:GALT) - Stock Price, News

Tags:Galectin stock price

Galectin stock price

GALT: Galectin Therapeutics Inc Stock Price Quote - Bloomberg

WebMar 25, 2024 · Galectin Therapeutics Price Performance The stock has a market cap of $116.84 million, a P/E ratio of -3.32 and a beta of 1.42. The firm’s fifty day moving average price is $1.63 and its two ... WebGlobeNewswire. May-28-19 09:05AM. Galectin Therapeutics Raises $44.5 Million in Rights Offering and $2.5 Million from Warrant Exercise. GlobeNewswire. Galectin Therapeutics …

Galectin stock price

Did you know?

WebApr 11, 2024 · See the latest Galectin Therapeutics Inc stock price (XMUN:PHPN), related news, valuation, dividends and more to help you make your investing decisions. WebMar 27, 2024 · Get Galectin Therapeutics Inc (GALT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

WebApr 13, 2024 · Galectin Therapeutics Price Performance Galectin Therapeutics stock opened at $2.04 on Thursday. The stock has a market capitalization of $121.26 million, … Web53 minutes ago · Galectin Inhibitors Drugs Have Emerged As New Focused Domain For Cancer Clinical Researchers Says Kuick Research. Delhi, April 14, 2024 (GLOBE NEWSWIRE) -- Global Galectin Inhibitors Market Trends & Clinical Trials Insight 2024 Report Highlights: Global Galectin Inhibitors Clinical Pipeline By Company, Indication & …

WebGalectin Therapeutic stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... It is based on a 60-month historical … WebWhat was the 52-week low for Galectin Therapeutics stock? The low in the last 52 weeks of Galectin Therapeutics stock was 1.03. According to the current price, Galectin Therapeutics is 188.35% ...

Web2 days ago · View Galectin Therapeutics Inc GALT investment & stock information. Get the latest Galectin Therapeutics Inc GALT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

WebApr 14, 2024 · Delhi, April 14, 2024 (GLOBE NEWSWIRE) -- Global Galectin Inhibitors Market Trends & Clinical Trials Insight 2024 Report Highlights: Global Galectin Inhibitors … my right fingers are tinglingWebGalectin stock lifts 15% premarket on early cancer combination trial results Tuesday, 18 September 2024 zacks. ... Price target. Current $1.70. Average $12.00. Low $12 High $12. Galectin Therapeutics Inc executives Insider Age Since Compensation; Harold Shlevin (71) Director since 2024 71: my right foot doesn\u0027t hurtWeb53 minutes ago · Galectin Inhibitors Drugs Have Emerged As New Focused Domain For Cancer Clinical Researchers Says Kuick Research. Delhi, April 14, 2024 (GLOBE … the shade room love lockedWebApr 13, 2024 · Galectin Therapeutics Price Performance. Shares of GALT opened at $2.04 on Thursday. Galectin Therapeutics has a one year low of $1.02 and a one year high of $2.57. The company has a market cap of ... the shade room nick cannonWebHistorical daily share price chart and data for Galectin Therapeutics since 2024 adjusted for splits. The latest closing stock price for Galectin Therapeutics as of March 22, 2024 is 1.97.. The all-time high Galectin Therapeutics stock closing price was 36.84 on September 11, 2003.; The Galectin Therapeutics 52-week high stock price is 2.57, which is 30.5% … the shade room lil nas xWebIn depth view into GALT (Galectin Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. Galectin Therapeutics Inc (GALT) 2.08 +0.07 ( +3.48% ) USD NASDAQ Apr 06, 16:00 the shade room net worthWebGalectin Therapeutics Inc lowest stock price was $1.02 and its highest was $2.57 in the past 12 months. What is Galectin Therapeutics Inc’s market cap? ... Following the earnings report the stock price went up 5.738%. Which hedge fund is a major shareholder of Galectin Therapeutics Inc? Currently, no hedge funds are holding shares in GALT--- the shade room jada pinkett smith